Association of Adenotonsillectomy with Asthma Outcomes in Children: A Longitudinal Database Analysis
Background:
Childhood asthma and obstructive sleep apnea (OSA), both disorders of airway inflammation, were associated in recent observational studies. Although childhood OSA is effectively treated by adenotonsillectomy (AT), it remains unclear whether AT also improves childhood asthma. We hypothesized that AT, the first line of therapy for childhood OSA, would be associated with improved asthma outcomes and would reduce the usage of asthma therapies in children.
Methods and Findings:
Using the 2003–2010 MarketScan database, we identified 13,506 children with asthma in the United States who underwent AT. Asthma outcomes during 1 y preceding AT were compared to those during 1 y following AT. In addition, 27,012 age-, sex-, and geographically matched children with asthma without AT were included to examine asthma outcomes among children without known adenotonsillar tissue morbidity. Primary outcomes included the occurrence of a diagnostic code for acute asthma exacerbation (AAE) or acute status asthmaticus (ASA). Secondary outcomes included temporal changes in asthma medication prescriptions, the frequency of asthma-related emergency room visits (ARERs), and asthma-related hospitalizations (ARHs). Comparing the year following AT to the year prior, AT was associated with significant reductions in AAE (30.2%; 95% CI: 25.6%–34.3%; p<0.0001), ASA (37.9%; 95% CI: 29.2%–45.6%; p<0.0001), ARERs (25.6%; 95% CI: 16.9%–33.3%; p<0.0001), and ARHs (35.8%; 95% CI: 19.6%–48.7%; p = 0.02). Moreover, AT was associated with significant reductions in most asthma prescription refills, including bronchodilators (16.7%; 95% CI: 16.1%–17.3%; p<0.001), inhaled corticosteroids (21.5%; 95% CI: 20.7%–22.3%; p<0.001), leukotriene receptor antagonists (13.4%; 95% CI: 12.9%–14.0%; p<0.001), and systemic corticosteroids (23.7%; 95% CI: 20.9%–26.5%; p<0.001). In contrast, there were no significant reductions in these outcomes in children with asthma who did not undergo AT over an overlapping follow-up period. Limitations of the MarketScan database include lack of information on race and obesity status. Also, the MarketScan database does not include information on children with public health insurance (i.e., Medicaid) or uninsured children.
Conclusions:
In a very large sample of privately insured children, AT was associated with significant improvements in several asthma outcomes. Contingent on validation through prospectively designed clinical trials, this study supports the premise that detection and treatment of adenotonsillar tissue morbidity may serve as an important strategy for improving asthma control.
Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Association of Adenotonsillectomy with Asthma Outcomes in Children: A Longitudinal Database Analysis. PLoS Med 11(11): e32767. doi:10.1371/journal.pmed.1001753
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001753
Souhrn
Background:
Childhood asthma and obstructive sleep apnea (OSA), both disorders of airway inflammation, were associated in recent observational studies. Although childhood OSA is effectively treated by adenotonsillectomy (AT), it remains unclear whether AT also improves childhood asthma. We hypothesized that AT, the first line of therapy for childhood OSA, would be associated with improved asthma outcomes and would reduce the usage of asthma therapies in children.
Methods and Findings:
Using the 2003–2010 MarketScan database, we identified 13,506 children with asthma in the United States who underwent AT. Asthma outcomes during 1 y preceding AT were compared to those during 1 y following AT. In addition, 27,012 age-, sex-, and geographically matched children with asthma without AT were included to examine asthma outcomes among children without known adenotonsillar tissue morbidity. Primary outcomes included the occurrence of a diagnostic code for acute asthma exacerbation (AAE) or acute status asthmaticus (ASA). Secondary outcomes included temporal changes in asthma medication prescriptions, the frequency of asthma-related emergency room visits (ARERs), and asthma-related hospitalizations (ARHs). Comparing the year following AT to the year prior, AT was associated with significant reductions in AAE (30.2%; 95% CI: 25.6%–34.3%; p<0.0001), ASA (37.9%; 95% CI: 29.2%–45.6%; p<0.0001), ARERs (25.6%; 95% CI: 16.9%–33.3%; p<0.0001), and ARHs (35.8%; 95% CI: 19.6%–48.7%; p = 0.02). Moreover, AT was associated with significant reductions in most asthma prescription refills, including bronchodilators (16.7%; 95% CI: 16.1%–17.3%; p<0.001), inhaled corticosteroids (21.5%; 95% CI: 20.7%–22.3%; p<0.001), leukotriene receptor antagonists (13.4%; 95% CI: 12.9%–14.0%; p<0.001), and systemic corticosteroids (23.7%; 95% CI: 20.9%–26.5%; p<0.001). In contrast, there were no significant reductions in these outcomes in children with asthma who did not undergo AT over an overlapping follow-up period. Limitations of the MarketScan database include lack of information on race and obesity status. Also, the MarketScan database does not include information on children with public health insurance (i.e., Medicaid) or uninsured children.
Conclusions:
In a very large sample of privately insured children, AT was associated with significant improvements in several asthma outcomes. Contingent on validation through prospectively designed clinical trials, this study supports the premise that detection and treatment of adenotonsillar tissue morbidity may serve as an important strategy for improving asthma control.
Please see later in the article for the Editors' Summary
Zdroje
1. Centers for Disease Control and Prevention National Center for Health Statistics (2011) National health interview raw data, 2011. Analysis by the American Lung Association Research and Health Education Division using SPSS and SUDAAN software. Atlanta (Georgia): Centers for Disease Control and Prevention.
2. Centers for Disease Control and Prevention National Center for Health Statistics (2010) National Hospital Discharge Survey, 1995–2010. Analysis by the American Lung Association Research and Health Education Division using SPSS software. Atlanta (Georgia): Centers for Disease Control and Prevention.
3. Centers for Disease Control and Prevention National Center for Health Statistics (2010) National Hospital Ambulatory Medical Care Survey, 2010. Analysis by the American Lung Association Research and Health Education Division using SPSS software. Atlanta (Georgia): Centers for Disease Control and Prevention.
4. BarnettSB, NurmagambetovTA (2011) Costs of asthma in the United States: 2002–2007. J Allergy Clin Immunol 127: 145–152.
5. BlakeK, TeagueWG (2013) Gastroesophageal reflux disease and childhood asthma. Curr Opin Pulm Med 19: 24–29.
6. HardingSM, RichterJE (1997) The role of gastroesophageal reflux in chronic cough and asthma. Chest 111: 1389–1402.
7. Figueroa-MunozJI, ChinnS, RonaRJ (2001) Association between obesity and asthma in 4–11 year old children in the UK. Thorax 56: 133–137.
8. LuderE, MelnikTA, DiMaioM (1998) Association of being overweight with greater asthma symptoms in inner city black and Hispanic children. J Pediatr 132: 699–703.
9. GennusoJ, EpsteinLH, PaluchRA, CernyF (1998) The relationship between asthma and obesity in urban minority children and adolescents. Arch Pediatr Adolesc Med 152: 1197–1200.
10. DesagerKN, NelenV, WeylerJJ, De BackerWA (2005) Sleep disturbance and daytime symptoms in wheezing school-aged children. J Sleep Res 14: 77–82.
11. RamagopalM, MehtaA, RobertsDW, WolfJS, TaylorRJ, et al. (2009) Asthma as a predictor of obstructive sleep apnea in urban African-American children. J Asthma 46: 895–899.
12. Kheirandish-GozalL, DayyatEA, EidNS, MortonRL, GozalD (2011) Obstructive sleep apnea in poorly controlled asthmatic children: effect of adenotonsillectomy. Pediatr Pulmonol 46: 913–918.
13. RossKR, Storfer-IsserA, HartMA, KiblerAM, RueschmanM, et al. (2012) Sleep-disordered breathing is associated with asthma severity in children. J Pediatr 160: 736–742.
14. Kheirandish-GozalL, GozalD (2012) Obesity, asthma, and sleep-disordered breathing. J Pediatr 160: 713–714.
15. AliNJ, PitsonDJ, StradlingJR (1993) Snoring, sleep disturbance, and behaviour in 4–5 year olds. Arch Dis Child 68: 360–366.
16. GislasonT, BenediktsdottirB (1995) Snoring, apneic episodes, and nocturnal hypoxemia among children 6 months to 6 years old. An epidemiologic study of lower limit of prevalence. Chest 107: 963–966.
17. Montgomery-DownsHE, O'BrienLM, HolbrookCR, GozalD (2004) Snoring and sleep-disordered breathing in young children: subjective and objective correlates. Sleep 27: 87–94.
18. MarcusCL, McColleySA, CarrollJL, LoughlinGM, SmithPL, et al. (1994) Upper airway collapsibility in children with obstructive sleep apnea syndrome. J Appl Physiol 77: 918–924.
19. ArensR, MarcusCL (2004) Pathophysiology of upper airway obstruction: a developmental perspective. Sleep 27: 997–1019.
20. GoldbartAD, KrishnaJ, LiRC, SerperoLD, GozalD (2006) Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 130: 143–148.
21. KimJ, BhattacharjeeR, DayyatE, SnowAB, Kheirandish-GozalL, et al. (2009) Increased cellular proliferation and inflammatory cytokines in tonsils derived from children with obstructive sleep apnea. Pediatr Res 66: 423–428.
22. BhattacharjeeR, KimJ, Kheirandish-GozalL, GozalD (2011) Obesity and obstructive sleep apnea syndrome in children: a tale of inflammatory cascades. Pediatr Pulmonol 46: 313–323.
23. MarcusCL, BrooksLJ, DraperKA, GozalD, HalbowerAC, et al. (2012) Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 130: 576–584.
24. BhattacharjeeR, Kheirandish-GozalL, SpruytK, MitchellRB, PromchiarakJ, et al. (2010) Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: a multicenter retrospective study. Am J Respir Crit Care Med 182: 676–683.
25. MarcusCL, MooreRH, RosenCL, GiordaniB, GaretzSL, et al. (2013) A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med 368: 2366–2376.
26. GozalD, SerperoLD, Sans CapdevilaO, Kheirandish-GozalL (2008) Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med 9: 254–259.
27. EricksonBK, LarsonDR, St SauverJL, MeverdenRA, OrvidasLJ (2009) Changes in incidence and indications of tonsillectomy and adenotonsillectomy, 1970–2005. Otolaryngol Head Neck Surg 140: 894–901.
28. MitchellRB, PereiraKD, FriedmanNR (2006) Sleep-disordered breathing in children: survey of current practice. Laryngoscope 116: 956–958.
29. GozalD (2010) Pediatric OSA: a case for “united we stand” in the way of a breath. Pediatr Pulmonol 45: 1151–1152.
30. VerhulstSL, VekemansK, HoE, AertsL, JacobsS, et al. (2007) Is wheezing associated with decreased sleep quality in Sri Lankan children? A questionnaire study. Pediatr Pulmonol 42: 579–583.
31. ValeryPC, MastersIB, ChangAB (2004) Snoring and its association with asthma in indigenous children living in the Torres Strait and Northern Peninsula Area. J Paediatr Child Health 40: 461–465.
32. TeculescuDB, CaillierI, PerrinP, RebstockE, RauchA (1992) Snoring in French preschool children. Pediatr Pulmonol 13: 239–244.
33. RedlineS, TishlerPV, SchluchterM, AylorJ, ClarkK, et al. (1999) Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 159: 1527–1532.
34. MarshallNS, AlmqvistC, GrunsteinRR, MarksGB (2007) Childhood Asthma Prevention Study (2007) Predictors for snoring in children with rhinitis at age 5. Pediatr Pulmonol 42: 584–591.
35. LuLR, PeatJK, SullivanCE (2003) Snoring in preschool children: prevalence and association with nocturnal cough and asthma. Chest 124: 587–593.
36. KaditisAG, KalampoukaE, HatzinikolaouS, LianouL, PapaefthimiouM, et al. (2010) Associations of tonsillar hypertrophy and snoring with history of wheezing in childhood. Pediatr Pulmonol 45: 275–280.
37. ErsuR, ArmanAR, SaveD, KaradagB, KarakocF, et al. (2004) Prevalence of snoring and symptoms of sleep-disordered breathing in primary school children in Istanbul. Chest 126: 19–24.
38. CorboGM, FuciarelliF, ForesiA, De BenedettoF (1989) Snoring in children: association with respiratory symptoms and passive smoking. BMJ 299: 1491–1494.
39. ChngSY, GohDY, WangXS, TanTN, OngNB (2004) Snoring and atopic disease: a strong association. Pediatr Pulmonol 38: 210–216.
40. KoYA, SongPX, ClarkNM (2014) Declines with age in childhood asthma symptoms and health care use. An adjustment for evaluations. Ann Am Thorac Soc 11: 54–62.
41. WeatherlyRA, MaiEF, RuzickaDL, ChervinRD (2003) Identification and evaluation of obstructive sleep apnea prior to adenotonsillectomy in children: a survey of practice patterns. Sleep Med 4: 297–307.
42. FriedmanNR, PerkinsJN, McNairB, MitchellRB (2013) Current practice patterns for sleep-disordered breathing in children. Laryngoscope 123: 1055–1058.
43. GozalD, CapdevilaOS, Kheirandish-GozalL (2008) Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med 177: 1142–1149.
44. GogateS, KatialR (2008) Pediatric biomarkers in asthma: exhaled nitric oxide, sputum eosinophils and leukotriene E4. Curr Opin Allergy Clin Immunol 8: 154–157.
45. PrasadB, NyenhuisSM, WeaverTE (2014) Obstructive sleep apnea and asthma: associations and treatment implications. Sleep Med Rev 18: 165–171.
46. IoachimescuOC, TeodorescuM (2013) Integrating the overlap of obstructive lung disease and obstructive sleep apnoea: OLDOSA syndrome. Respirology 18: 421–431.
47. DixonAE (2009) Rhinosinusitis and asthma: the missing link. Curr Opin Pulm Med 15: 19–24.
48. Van DoleKB, SwernAS, NewcombK, NelsenL (2009) Seasonal patterns in health care use and pharmaceutical claims for asthma prescriptions for preschool- and school-aged children. Ann Allergy Asthma Immunol 102: 198–204.
49. SearsMR (2008) Epidemiology of asthma exacerbations. J Allergy Clin Immunol 122: 662–668.
50. GozalD, ShataA, NakayamaM, SpruytK (2011) Seasonal variability of sleep-disordered breathing in children. Pediatr Pulmonol 46: 581–586.
51. SaitoH, AsakuraK, HataM, KatauraA, MorimotoK (1996) Does adenotonsillectomy affect the course of bronchial asthma and nasal allergy? Acta Otolaryngol Suppl 523: 212–215.
52. BusinoRS, QuraishiHA, AguilaHA, MontalvoE, ConnellyP (2010) The impact of adenotonsillectomy on asthma in children. Laryngoscope 120(Suppl 4): S221.
53. CrockerD, BrownC, MoolenaarR, MoormanJ, BaileyC, et al. (2009) Racial and ethnic disparities in asthma medication usage and health-care utilization: data from the National Asthma Survey. Chest 136: 1063–1071.
54. BlixenCE, HavstadS, TilleyBC, ZorattiE (1999) A comparison of asthma-related healthcare use between African-Americans and Caucasians belonging to a health maintenance organization (HMO). J Asthma 36: 195–204.
55. GillilandFD, BerhaneK, IslamT, McConnellR, GaudermanWJ, et al. (2003) Obesity and the risk of newly diagnosed asthma in school-age children. Am J Epidemiol 158: 406–415.
56. EwingR, BrownsonRC, BerriganD (2006) Relationship between urban sprawl and weight of United States youth. Am J Prev Med 31: 464–474.
57. StathamMM, MyerCM3rd (2010) Complications of adenotonsillectomy. Curr Opin Otolaryngol Head Neck Surg 18: 539–543.
58. GoldmanJL, BaughRF, DaviesL, SkinnerML, StachlerRJ, et al. (2013) Mortality and major morbidity after tonsillectomy: etiologic factors and strategies for prevention. Laryngoscope 123: 2544–2553.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2014 Číslo 11
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Vztah mezi statiny a rizikem vzniku nádorových onemocnění − metaanalýza
- Nech brouka žít… Ať žije astma!
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
Najčítanejšie v tomto čísle
- Act II of the Sunshine Act
- Computerized Cognitive Training in Cognitively Healthy Older Adults: A Systematic Review and Meta-Analysis of Effect Modifiers
- What Could Computerized Brain Training Learn from Evidence-Based Medicine?
- Sublingual Misoprostol versus Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage in Uganda: A Double-Blind Randomized Non-Inferiority Trial